Effects of HIV Counseling and Testing
on Sexual Risk Behavior:
A Meta-Analytic Review of
Published Research, 1985-1997
Lance S. Weinhardt, MS, Michael P. Carey, PhD, Blair T Johnson, PhD, and
Nicole L. Bickham, MS
Opportunistic infections resulting from
AIDS remain a leading cause of premature
death in the United States. More than 400000
people have died of AIDS-related complications, and more than 250000 adults and children are living with AIDS.' An additional
630000 to 900000 people are infected with
HIV but have not yet developed the conditions required for a diagnosis of AIDS.2
Worldwide, the problems of HIV infection
and AIDS are even greater.3'4 Anti-retroviral
treatments for HIV disease can improve quality of life and delay AIDS-related deaths5'6;
despite these advances, however, there is currently no cure or vaccine for HIV infection.
Thus, the best way to prevent infection is to
avoid behaviors that result in contact with the
blood, semen, or vaginal fluids of an HIVinfected individual.7'8
HIV counseling and testing (HIV-CT) is
the largest and most costly HIV prevention
effort in the United States. Expanded use of
HIV-CT as a prevention strategy has also
been advocated in developing countries.9 The
primary objectives of the HIV-CT system are
(1) to provide an opportunity for persons to
learn their HIV serostatus and, if infected, to
obtain referrals for medical and psychosocial
care, and (2) to provide counseling so that
clients might change their behavior to avoid
infection or, if already infected, to avoid
transmitting the virus to others.'0 To achieve
the latter objective, the Centers for Disease
Control and Prevention (CDC) recommends
a client-centered counseling approach,
including personalized risk assessment,
development of a personalized risk reduction
plan, and referrals appropriate to the client's
test results.'0 In this article we focus on the
effectiveness of HIV-CT in achieving this
objective.
As of 1992, approximately 60 million
Americans (one third of the adult population)
had been tested for HIV antibodies' 1,12; 50%
of the tests were performed at publicly
funded sites."3 From 1989 to 1995, more than
2 million people were tested annually at public sites, with 1 million people tested for the
first time each year.'3'14 A cost-benefit analysis of the CDC's national HIV-CT program'5
revealed that over $100 million is allocated
annually by the CDC to more than 5000 sites
across the United States and its territories.16
Clearly, HIV-CT provides an opportunity to
perform individualized HIV risk behavior
interventions with more people than any
other single HIV prevention program. It is
crucial that such a widespread and costly program fulfill its purpose and that its effectiveness be evaluated.
Previous reviews of the HIV-CT literature have concluded that couples who are
serodiscordant for HIM when tested and counseled together, reduce their risk behavior, but
that the effects of HIV-CT on sexual risk
behavior in other groups remain largely uncertain because of inconsistencies in study outcomes.16-22 However, the most recent comprehensive review of studies examining the
effects of HIV-CT on HIV risk behavior19 was
published more than 7 years ago, and new
data are now available. Moreover, confidence
in the conclusions of earlier reviews is limited
because they were guided by qualitative interpretations rather than empirical synthesis.2324
In this article we present a comprehensive meta-analytic review of the effects of
HIV-CT on sexual behavior that places the
participants at risk for HIV infection. We
focused exclusively on sexual behavior
because sexual behavior remains the primary
vector for transmission of HIV' and because
The authors are with the Department of Psychology, Syracuse University, Syracuse, NY.
Requests for reprints should be sent to Michael
P. Carey, PhD, Department of Psychology, Syracuse
University, 430 Huntington Hall, Syracuse, NY
13244-2340 (e-mail: mpcarey(syr.edu).
This paper was accepted December 10, 1998.
American Journal of Public Health 1397
Weinhardt et al.
we wanted a sample of study outcomes that
were conceptually and methodologically similar. We excluded unpublished data (e.g., conference abstracts, doctoral dissertations) for 2
reasons. First, because the published reports
included many nonsignificant findings, we
reasoned that if a publication bias does exist in
the HIV-CT literature, it is probably based
more on methodological quality than on the
pattern of results. Second, most data contained
in conference abstracts were subsequently
published in the peer-reviewed literature.
Previous narrative reviews and the risk
reduction goals of HIV-CT led to the hypotheses that study participants who received an
HIV-positive test result, individually or with a
partner, would exhibit greater risk reduction
than HIV-negative participants, who, in turn,
would exhibit greater risk reduction than
untested participants. We tested this hypothesis and, in addition, hypotheses about moderating variables that might explain variations
in effect sizes across studies.
Methods
Sample of Studies
Studies were identified through 3 methods: (1) computer searches of MEDLINE and
PsycLIT databases from January 1985 (the
year that HIV antibody testing was approved
for public use) through June 1997, using combinations of the key words AIDS, HIV< test*
(the asterisk indicates a wildcard operator;
i.e., all terms starting with test were retrieved),
counseling, serodiagnosis, serostatus, sex*,
and behavior; (2) manual searches of the journals AIDS, AIDS Care, AIDS Education and
Prevention, American Journal of Public
Health, Health Psychology, Journal of the
American Medical Association, and Sexually
Transmitted Diseases for the years 1985
through 1997; and (3) inspection of the reference lists of all identified articles. The latter
method was repeated until all potentially relevant articles from these sources were identified.
Identified studies were included if they
provided (1) assessment of when, relative to
data collection, participants underwent HIVCT; (2) sexual behavior outcome data or a
proxy measure (e.g., sexually transmitted disease [STD] incidence); (3) 2 or more assessments with the same participants, to allow
examination of behavior change over time;
and (4) summary or inferential statistics sufflcient for the calculation of within-group effect
sizes. Thirty-four studies met criteria 1
through 3. With regard to criterion 4, two
studies 25,26 were excluded because they provided neither the significance level for the relevant within-group comparison nor other data
1398 American Journal of Public Health
needed to make the comparisons. Finally,
when more than 1 study presented data from
the same participants, only the study with the
most direct examination of the effects of HIVCT was included; this criterion resulted in the
exclusion of 6 studies.2732
some studies (e.g., length of follow-up in
days). Discrepancies in coding were resolved
by discussion and further examination of the
studies.
Study Characteristics Coded
The effect size used in this investigation
was d, the standardized mean difference
index,34 which was computed from sexual
risk behavior data from before and after HIVCT. The effect size d can range from zero to
plus or minus any number of standard deviations, depending on the direction and magnitude of the effect. Conventionally speaking,
an effect size of ±0.20 is "small," a value of
±0.50 is "medium," and values exceeding
±0.80 are "large."35 As in the case of most
meta-analyses of intervention studies, effect
sizes were expressed in such a way that positive effect sizes indicated reductions in sexual
risk behavior.
Effect sizes were calculated on the basis
of means and standard deviations, or if these
were not available, on the basis of proportions or other data (e.g., n and F, t, or X2 values). If only n's and significance levels were
presented, this information was used to estimate effect sizes. We used the pooled standard deviation in cases where only the mean
and standard deviation were presented. Compared with the use of paired observations, use
of the pooled standard deviation results in
effect sizes that may be biased toward zero.
When authors reported dichotomous outcomes, such as the proportion of participants
who engaged in unprotected sex during specified periods before and after the counseling
and testing, we treated the proportions as
means and derived the pooled standard deviation by following commonly available equations.34 3639A correction for bias due to sample size was applied to the calculated effect
sizes, resulting in the effect size statistic d
used for analysis.36
For each study, within-group effect sizes
were computed separately for each sexual
behavior outcome for each group (HIV-positive, HIV-negative, and untested participants;
serodiscordant couples; and mixed samples).
Effect sizes for serodiscordant couples and
mixed samples were calculated separately
because these 2 groups differ from the other
3 (i.e., each effect size includes data from
both HIV-positive and HIV-negative participants). If a study offered more than 1 followup assessment of intervention effectiveness,
data from the first follow-up assessment were
used. This strategy resulted in a set of 106
effect sizes. When a study yielded more than
1 effect size for the same outcome in the
same serostatus group, these effect sizes were
averaged, reducing the number of effect sizes
Study characteristics were coded with 2
goals in mind: description and explanation.
Characteristics that described the studies
were year of publication, dates of data collection, and geographic location (city, state, and
country). Characteristics that described the
participants were educational attainment (in
years); race/ethnicity (proportion White,
African American, and Latino, or international sample); sexual orientation (proportion
heterosexual, homosexual, bisexual); and
identified risk group (men who have sex with
men, injection drug users, socially or economically disadvantaged group, in HIVendemic area or not).
Characteristics that provided information
about the predictor variables were number of
participants who were tested, number who
received a positive test result for HIV, number
who received a negative test result for HIF and
number who were untested. Characteristics of
counseling that were coded were presence or
absence of personalized risk assessment;
inclusion of information about transmission
routes; inclusion of information about preventive behavior; explanation of HIV antibody
testing; education about proper condom use;
peer group discussion; partner notification;
and number of minutes of pretest and posttest
counseling. Characteristics related to the sexual risk behavior outcome variables were level
of measurement (categorical, ordinal, ratio);
type of risk behavior (number of sexual partners, condom use, unprotected intercourse,
proxy measure); and length of reporting
period (in days). Finally, potential moderators
of study effect sizes were coded: sex of participants (proportion female); average age of participants (in years); volition for HIV-CT
(sought HIV-CT, accepted HIV-CT as part of a
study, or mandated to receive HIV-CT); HIV
seroprevalence in sample (number of infected
participants divided by the total number of
participants); attrition rate (proportion of participants who did not return for the follow-up
assessment); and length of follow-up (in days).
All study characteristics were coded
independently by 2 raters. Reliability of the
coding was evaluated for each category by
computing K values for interrater agreement
across all studies33; K values ranged from
0.81 to 1.00 (median = 0.97). Lower interrater reliability resulted from categories containing values that had to be estimated for
Computation and Analysis of Effect Sizes
September 1999, Vol. 89, No. 9
HIV Counseling and Testing
in the data set to 73. Thus, to avoid violating
the assumption of independence of effect
sizes, each participant was included in only 1
effect size for each outcome.
Analyses followed fixed-effects procedures,39 which assign greater weight to effect
sizes from larger studies on the assumption
that larger sample sizes provide more reliable
outcomes. The weighted mean effect size, d+,
is an average of the individual studies' effect
sizes weighted by the inverse of their variance
(i.e., sample size). To determine whether models implied by weighted mean effect sizes
describe studies' effect sizes correctly, a homogeneity-of-variance statistic, Q, was computed.39 Q has an approximate X2 distribution
with degrees of freedom equal to the number
of effect sizes (k) minus 1. A significant Q
indicates that the d+ may not adequately
describe the variability in outcomes in a given
set of studies. Variability in the magnitude of
effect sizes was explained by relating the effect
sizes to the studies' characteristics.
Categorical models, based on analysis of
variance, and continuous models, based on
least squares regression models, were evaluated to test relationships between study characteristics and outcomes. For categorical models,
the homogeneity statistic QB (between-groups
homogeneity) was used to compare d+ across
different groups of studies or participants; a
significant test result indicates group differences in d,. QB has an approximate X2distribution with m- I df where m is the number of
classes. Within the classes established by the
groupings in these models, Qwi assesses
whether the d+ for each class i describes the
effects of the studies within the class correcty.
Like Q, QW. has an approximate j2distribution
with 1-I df where lis the number ofstudies in
each class i. Homogeneity was evaluated for all
moderator analyses, with a significant homogeneity index, QE' indicating that variance
remains unexplained. QE has an approximate
x2 distribution with k- p-1 df wherep is the
number of carriers in the model. Separate
analyses were conducted for each of the sexual
behavior outcomes that were typically reported
(i.e., number of partners, condom use, and
unprotected intercourse).
Sensitivity analyses were conducted by
computing fail-safe n's for group differences
found in the primary analyses. The fail-safe n
is the number of additional studies averaging
no difference that it would take to decrease an
observed mean effect size to a particular
value. To compute this statistic in the present
context, we followed Orwin's formulation,40
nfaiI-,fe = k(d+ dd / dc,
-
where k is the number of studies in the mean
effect size, d+ is the mean effect size, and dr
September 1999, Vol. 89, No. 9
is the comparison effect size of interest. In
the present context, the comparison for each
outcome was the observed mean effect size
involving untested participants. The resulting fail-safe n's are relatively conservative estimates of the number of studies required to
nullify differences between the 2 mean effect
sizes.
Results
Summary ofMethodological Features of
HIV-CT Studies
Twenty-seven studies,4147 representing
a total of 19 597 participants, met the inclusion criteria. The number of tested participants in the studies ranged from 14 to 1080;
the number of untested participants ranged
from 12 to 4524. Sixty-eight percent of the
studies reported attrition rates, which ranged
from 5% to 89% (mean= 33%). Nineteen
(70%) of the studies were conducted in
North America, 6 (22%) were conducted in
Africa, and 2 (8%) were conducted in Europe.
Time elapsed prior to the first follow-up
assessment ranged from 16 days to 4 years
(median = 180 days).
Five types of research design appeared
in the sample: (1) cohort studies that compared behavioral data collected before and
after antibody testing was introduced (in
1985) and assessed whether participants had
been tested and, if so, the results (8%); (2)
cohort studies that compared the behavioral
responses of individuals whose blood was
sampled for the study and who chose to be
told their test results and receive counseling
with those of individuals who also had their
blood sampled but chose not to receive their
results (32%; the latter participants were considered "untested" for the purposes of this
review because they did not learn their test
results or receive counseling); (3) studies that
compared behavioral data collected before
and after testing was conducted among people who sought HIV-CT at a testing site, people who were offered and accepted testing, or
people in treatment for injection drug use
(44%); (4) studies in which participants (who
did not originally plan to be tested) were randomly assigned to testing or to 1 or more
control groups (12%); and (5) one study that
compared prenotification and postnotification data among people who tested HIV-positive when donating blood and received counseling with their test results (4%). Detailed
study characteristics appear in Table 1.
The studies generally provided little or
no detail about the counseling used. Only 4
studies mentioned the length of counseling
sessions, and 7 studies provided no informa-
tion at all. Although 5 studies supplemented
counseling with other components, including
peer-group discussion,55 videotaped presenta42 and partner counseling,42 53'61 these
tions, 4142,5,6
reports did not include details of the counseling procedures. Typically, studies did not
indicate whether procedures adhered to federal or other HIV-CT guidelines. Because of
the inconsistent amount of information
reported, moderator analyses using characteristics of counseling could not be conducted.
Outcomes typically assessed were number of sexual partners, condom use, and
unprotected intercourse. Information about
these variables was obtained via interviews or
self-administered questionnaires with different levels of specificity and precision (e.g.,
reporting periods ranged from 10 days to 2
years). Two studies provided data on HIV or
STD incidence.41'6
Primary Analyses
The 73 effect sizes used in the primary
analyses represent data from 6558 tested and
6685 untested participants. Table 2 displays
the effect sizes by behavior, and Figure 1
depicts the results of analyses by behavior
and group.
Unprotected intercourse. Twenty-one
effect sizes were based on unprotected-intercourse data. As hypothesized, the weighted
mean effect sizes for the HIV-positive group
(d+ = 0.47; 95% confidence interval [CI] =
0.32, 0.61) and the serodiscordant couple
group (d+ = 0.75; 95% CI = 0.59, 0.92)
indicated significant risk reduction, and both
were greater than the weighted mean effect
size for the untested participants (d+ = 0.16;
95% CI = 0.07, 0.25) [QB(i) = 12.67, P <
.001, and QB(1) = 37.23, P < .001, respectively]. Contrary to prediction, however, the
HIV-negative participants (d+= 0.19; 95%
CI = 0.08, 0.31) did not reduce their frequency of unprotected intercourse relative to
untested participants [QB(l) = 0.17, not significant (NS)]. Effect sizes in the untested
and HIV-serodiscordant couple groups were
homogeneous. Sensitivity analyses for the
unprotected-intercourse outcome revealed
that it would take 7 studies with null results to
reduce the serodiscordant-couple mean effect
size to the same value as that for the untested
participants, and it would take 10 studies with
null results to reduce the mean effect size for
the HIV-positive individuals to be statistically
equivalent to that of the untested participants.
Condom use. Twenty-two effect sizes were
based on condom-use measures. Weighted
mean effect sizes for the HIV-positive group
(d+ = 0.65; 95% CI = 0.42, 0.87) and the
serodiscordant-couple group (d+= 1.31; 95%
CI = 1.14, 1.48) were positive, significant,
American Journal of Public Health 1399
Weinhardt et al.
TABLE 1-Characteristics of Studies Included in a Meta-Analysis of 27 Studies of HIV Counseling and Testing (HIV-CT)
Sample Characteristics
Author (Year)
Designa
Location
.. Al
_
.
C
C (couples)
D
B
E
A
B
B
1666
57
313
81
271
502
309
1001
A
B
C
C
C (couples)
C
307
155
230
556
149
57
C
C
C
B
B
C
C (couples)
B
48
4267
200
933
474
5522
144
31
Schechter et al. (1988)63
Wenger et al. (1991)64
Wenger et al. (1 992)65
Wilson et al. (1996)66
Zapka et al. (1991)67
B
D
D
C
B
Vancouver, BC
Los Angeles, Calif
Los Angeles, Calif
Brooklyn, NY
Boston, Mass
Source
n
Kigali, Rwanda
Kigali, Rwanda
Seattle, Wash
New York, NY
New York, NY
San Francisco, Calif
San Francisco, Calif
Baltimore, Md;
Washington, DC
van Griensven et al. (1989)49 Amsterdam
Huggins et al. (1991)50
Pittsburgh, Pa
New Haven, Conn
Ickovics et al. (1 994)51
Jackson et al. (1997)52
Nairobi, Kenya
Kamenga et al. (1991)53
Kinshasa, Zaire
Durham and
Landis et al. (1992)"4
Wake counties, NC
New York, NY
Magura et al. (1990)55
McCusker et al. (1996)"6
Worcester, Mass
MOller et al. (1992)57
Kampala, Uganda
Northern Italy
Nicolosi et al. (1991)58
Ostrow et al. (1989)59
Chicago, IlIl
Otten et al. (1 993)60
Miami, Fla
San Francisco, Calif
Padian et al. (1 993)61
The Gambia
Pickering et al. (1 993)62
Allen et al. (1992)41
Allen et al. (1992)42
Calsyn et al. (1992)43
Casadonte et al. (1990)44
Cleary et al. (1991)45
Coates et al. (1 987)46
Doll et al. (1990)47
Fox et al. (1 987)48
361
370
186
808
249
Days to
% % Hetero- First
Mean
Age, y Female sexual Follow-Up
_
90
Prenatal and pediatric clinics
Prenatal and pediatric clinics
IDU treatment facility
MMTP
Blood donors
Community cohort study
Community cohort study
Community cohort study
29.0
32.5
39.1
37.0
27.0
NR
37.0
36.0
100
50
32
0
22
0
0
0
NR
100
NR
100
45
0
0
0
90
120
70
16
760
501
180
Community cohort study
Community cohort study
36.0
NR
30.8
29.0
35.5
30.0
0
0
100
0
50
30
0
0
100
100
100
12
180
180
90
104
50
365
NR
NR
25.0
25.0
35.5
25.0
34.0
NR
38
32
33
23
0
27
50
100
NR
NR
NR
NR
0
NR
100
NR
90
365
180
312
365
180
180
30
NR
27.0
23.0
30.0
31.6
0
33
72
100
0
0
NR
100
100
0
730
56
180
120
1460
Community health clinics
Trucking company employees
Factory HIV screening program
County health departments
MMTP
IDU programs and correctional facilities
Public HIV-CT site
Drug treatment centers
MACS
STD clinic chart review
Various HIV-CT sites
Prostitutes at Medical
Research Council clinics
Community cohort study
University health clinic
STD clinic
Gynecology and family planning clinics
Community health center
Note. NR = not reported; IDU = injection drug use; MMTP = methadone maintenance treatment program; MACS = Multicenter AIDS Cohort
Study; STD = sexually transmitted disease.
aStudy designs were as follows: A = cohort study comparing behavioral data collected before and after antibody testing was introduced and
assessing whether participants had been tested and the result; B = cohort study comparing behavioral responses of participants whose
blood was sampled for a study and who chose to receive test results and counseling with those of individuals who also had blood drawn but
who chose not to receive test results; C = study comparing behavioral data collected before and after testing was conducted among people
who sought testing, people who were offered and accepted testing, or people in treatment for injection drug use; D = study in which
participants (who did not originally plan to be tested) were randomly assigned to testing or to a control group; E = study comparing
prenotification and postnotification behavioral data among people who tested HIV-positive when donating blood and received counseling with
their test results.
and homogeneous, and, as predicted, both
were greater than the weighted mean effect
size for the untested participants [QB(M) =
16.42, P < .001, and QB(l) = 147.43, P < .001,
respectively]. Once again, HIV-negative participants (d+ = 0.05, 95% CI = -0.02, 0.13)
did not increase their condom use more than
those who were untested (d+ = 0.15, 95%
CI = 0.08, 0.17) [QB(1) = 3. 10, NS]. Sensitivity analyses for the condom-use outcome
revealed that it would take 23 studies with
null results to reduce the serodiscordantcouple mean effect size to the same value as
that for the untested participants, and it would
take 13 studies with null results to reduce the
mean effect size for the HIV-positive individuals to be statistically equivalent to that of the
untested participants.
Number of sexual partners. Twenty-five
effect sizes were based on number of sexual
1400 American Journal of Public Health
partners. The weighted mean effect size for the
HIV-positive group was significantly positive
(d+= 0.34; 95% CI = 0.20,0.47). The weighted
mean effect size for the HIV-negative group
(d+ = 0.20; 95% CI = 0.14, 0.26) was also positive and significant. Contrary to predictions,
however, neither the HIV-positive group nor
the HIV-negative group exhibited greater
change than the untested group (d+ = 0.24;
95% CI = 0.17, 0.30). There was significant
heterogeneity of effect sizes in each group.
There were no data on numbers of sexual partners from studies of serodiscordant couples.
HIV and STD incidence. Four additional
effect sizes based on HIV and STD incidence
data were available from 2 studies.4160 These
data indicated that the incidence ofSTD infection decreased among HIV-positive participants (d+ = 0.15, 95% CI = 0.04, 0.26) but
increased among HIV-negative participants
(d+ =-0.17, 95% CI =-0.27, -0.06) and
among untested participants (d+ = -0.05,
95% CI = -0.09, -0.01). The weighted mean
effect size for HIV-positive participants was
significantly greater than those for the HIVnegative and untested participants. The difference between the HIV-negative group
and the untested group approached significance [QB(1)= 3.53, P =.06]. In the one
study presenting data on changes in HIV
incidence from before and after HIV-CT, 41
the effect did not differ from zero (d+ = 0.09,
95% CI = -0.01, 0.17).
To assess whether studies that contributed only one effect size to the analyses
affected the results, we also conducted analyses
by group and behavior, using only matched
samples (i.e., using only studies that contributed both an HIV-positive or HIV-negative and an untested effect size for each out-
September 1999, Vol. 89, No. 9
HIV Counseling and Testing
TABLE 2-Weighted Mean Effect Size and Related Statistics, by Sexual Risk Behavior and Participants' Serostatus Group,
for 27 Studies of HIV Counseling and Testing
Behavior and Group
Unprotected intercourse
HIV+
HIVDiscordant couples
Untested
Condom use
HIV+
HIVDiscordant couples
Untested
No. of sexual partners
HIV+
HIVUntested
d.
QB
95% Confidence Interval
k
n
Q
0.47a
45-96
(0.32, 0.61)
(0.08, 0.31)
(0-59, 0.92)
(0.07, 0.25)
5
7
2
5
402
599
293C
939
19.2 b
27.94
2.20
4.41
191.56
(0.42, 0.87)
(-0.02, 0.13)
(1.14,1.48)
(0.08, 0.23)
4
9
3
5
160
1238
329c
1276
4.23
13.72
(0.20, 0.47)
(0.14, 0.26)
(0.17, 0.30)
5
12
8
419
2061
1691
0.19
0.75a
0.16
0.65a
0.05
1.31a
0.15
3.4
0.34
0.20
0.24
24.82b
60.74
10.03
66.91b
21.04b
Note. d+ = Mean effect size weighted by sample size (the direction of the effect size for each behavior is such that a positive value reflects a
decrease in risk for HIV infection); QB = between-group homogeneity statistic for mean weighted effect size; k= number of studies
contributing an effect size; QW = within-group homogeneity statistic.
is greater than that of the untested group (P < .05).
ad+
bSignificant at P < .05.
CNumber of couples.
come). The pattern of results was identical to
that from the primary analyses, although
because of lower statistical power, some
group differences did not remain significant.
Moderator Analyses
For each potential moderator of effect
size, analyses were conducted with tested
participants across serostatus groups for each
outcome, and the effects of serostatus were
statistically controlled. The results of these
analyses are shown in Table 3. For each
analysis, significant heterogeneity remained
after application of the moderator.
Seroprevalence. Seroprevalence in the
sample was positively associated with risk
reduction in terms of unprotected sex (
[standardized [B weight] = .86, P< .005), but
did not moderate condom use (p= .04, NS)
or number of sexual partners (fi= .02, NS).
Age. The average age of participants was
a significant moderator of HIV-CT effect size
for condom use. Age was positively associated with risk reduction in terms of condom
use (,= .25, P < .005), but was not a moderator of unprotected sex = .09, NS) or number of sexual partners ( = -.14, NS).
Sex. The proportion of female participants in the samples did not moderate effect
sizes for unprotected intercourse (p = .09,
NS), condom use =-.04, NS), or number
of sexual partners (5 = .17, NS).
Attrition rate. Attrition rate did not moderate effect sizes for unprotected intercourse
(I =-.01, NS), condom use = .05, NS), or
number of sexual partners (i= -.22, NS).
September 1999, Vol. 89, No. 9
Length offollow-up. Length of time
between receipt of test results and the first
follow-up assessment was positively associated with effect size for number of sexual
partners (,B = .53, P< .005). However, length
of follow-up was not associated with effect
sizes for condom use (B= -.01, NS) or
unprotected intercourse (p =-.2 1, NS).
Volition for testing. The weighted mean
effect size for unprotected intercourse
among participants who sought testing
(d+ = 0.52, 95% CI = 0.38, 0.65) was larger
than the corresponding effect size among
participants who were offered and accepted
testing as part of a study (d+ = 0.35, 95%
CI 0.26, 0.45) [QB(M) = 4.09, P < .05].
There were no differences between these 2
groups in effect sizes for condom use or
number of sexual partners.
Injection drug use treatment. For condom use, the weighted mean effect size
among tested participants who were in treatment for injection drug use (d+ = 0.04, 95%
CI = -0.07, 0.15) was not different from zero
and homogeneity was nonsignificant [QW=
1.99, NS]. The weighted mean effect size for
condom use was larger among other participants (d+ = 0.44, 95% CI = 0.35, 0.52) than
among participants in treatment for injection
drug use [QB(1) = 31.52, P < .001]. Participants who were in treatment for injection
drug use did not modify their level of unprotected intercourse (d+=-0.11, 95% CI=
-0.56, 0.33), whereas participants who were
not in treatment exhibited a significant reduction in unprotected intercourse (d+= 0.37,
95% CI = 0.29, 0.45) [QB(1) = 4.44, P < .05].
=
Random-Effects Analyses
In a parallel set of analyses conducted to
test the robustness of our fixed-effects analyses, we also conducted the a priori hypothesis
analyses with randomeffects assumptions.68 Compared with fiedeffects procedures, random-effects procedures generally yield more conservative
results in terms of significance testing. The
pattern of findings remained identical under
random-effects assumptions, with one exception: for the unprotected-intercourse outcome, the mean effect size among HIV-positive participants was no longer different from
that of untested participants. The randomeffects analyses of continuous moderators
yielded the same pattern of results as the
fixed-effects analyses.
tests and moderator
Discussion
Overall, HIV-positive participants and
HIV-serodiscordant couples in the 27 studies
examined reduced their frequency of unprotected intercourse and increased their condom
use, relative to HIV-negative and untested participants, after receiving HIV counseling and
testing. Furthermore, in 2 studies, HIV-posifive participants exhibited reduced STD incidence relative to HIV-negative and untested
participants. These findings indicate that
HIV-CT is an effective secondary HIV prevention strategy; that is, participants who
learned that they were HIV-positive did
reduce their sexual risk behavior, thereby
American Journal of Public Health 1401
Weinhardt et al.
1.6 -
- 1.6
1.4 -
- 1.4
i:
1.2 -
- 1.2
.L
I1-
d.
.8
-1I
-L~~~~~~~~~~~~~~~~~~~~~~~~~~
-
:~ ~ ~ ~ ~ ~ ~ ~ ~:~~~~~~~~~~~~~~~~~~~~~~~~
(, :
T~~~~~~~~~~~~~~~~~~~~~~~~~
:
.6 -
.4 -
i
.2 0-
3+ -.2
-
a
b
c
d
Condom Use
a
b
c
d
Unprotected Sex
0
--1-
b c d
No. of Partners
Note. a = HIV-serodiscordant couples; b = HIV-positive participants; c = HIV-negative
participants; d = untested participants.
FIGURE 1-Weighted mean effect size (with 95% confidence interval) for HIV
counseling and testing from 27 published studies, by type of risk
behavior and participants' HIV serostatus group.
decreasing their risk of subsequent reinfection and their risk of infecting others. Participants who received a negative HIV test
result, however, did not modify their sexual
risk behavior any more than individuals who
did not participate in counseling and testing.
Therefore, HIV-CT does not appear to be an
effective primary prevention strategy.
The finding that HIV-positive participants reduced their frequency of unprotected
intercourse, relative to untested participants,
was not supported by subsequent randomeffects analysis. This discrepancy may indicate that the significant finding, observed
under fixed-effects assumptions, is not robust.
However, the significant reduction in STD
incidence is additional evidence that HIVpositive participants did reduce their frequency of unprotected intercourse in addition to increasing their use of condoms. The
results of all other random-effects analyses
were equivalent to those obtained with fixedeffects procedures.
Moderator analyses revealed several factors associated with the variation in study
results, beyond the effects of serostatus group,
for each ofthe major sexual behavior outcomes.
In response to HIV-CT, samples with higher
seroprevalence tended to decrease their frequency of unprotected intercourse more than
did samples with lower seroprevalence. St.
Lawrence et al.69 showed that men living in a
city with a high prevalence of HIV infection
1402 American Journal of Public Health
were more likely than men living in a lowprevalence city to be exposed to HIV prevention messages, to know of others infected
with HIVM and to possess accurate information about HIV and AIDS. This increased
awareness may result in heightened perceptions of risk and intentions to change behavior, which combine with HIV-CT to result in
risk reduction.
Three participant characteristics moderated the effectiveness of HIV-CT. First, older
samples increased their condom use more
than did younger samples. This finding may
reflect a general trend toward more risk
reduction among older persons, perhaps
because of maturity or stability of relationships, or because actual or perceived control
ofcondom use increases with age.
Second, participants who autonomously
sought HIV-CT reduced their frequency of
unprotected intercourse more than those who
were offered HIV-CT as part of a research
program. Participants who sought testing
may have used testing as part of a risk reduction plan67'70 or may have been more actively
contemplating behavior change. This finding
also indicates that to gain a better understanding of the effectiveness of HIV-CT, future
studies should be conducted at testing sites
with individuals who are seeking testing;
research with participants who are not seeking testing may not accurately represent the
effects of HIV-CT as it is implemented. Simi-
larly, studies in which the participants came
from injection drug use treatment programs
did not find significant behavior changes
with regard to condom use or unprotected
intercourse, compared with studies using participants from other sources. This result was
anticipated, because the emphasis of HIV-CT
for participants in injection drug use treatment is often on needle-sharing rather than
sexual behavior. Because sexual contact with
individuals infected with HIV through injection drug use is a significant source of HIV
infection,' efforts are needed to improve the
sexual risk reduction effects of HIV-CT in
this group.
Finally, studies that had longer followup periods had larger effect sizes for number
of sexual partners. This finding may reflect
the fact that number of sexual partners is an
outcome that is not sensitive to change during
shorter intervals.
A caveat about the results of the moderator analyses is warranted. The heterogeneity
of effect sizes within serostatus groups and
the remaining unexplained variance in the
analysis of continuous moderators suggest
that other moderators would more completely explain the variation in study outcomes. We discuss some of these potential
moderators below.
Critique of the Literature
Two limitations of the reviewed studies
merit discussion. First, the heterogeneity of
effect sizes and the number of significant moderators suggest that participants' responses to
HIV-CT are multiply determined and complex. However, with only a few exceptions,
HIV-CT studies have not been informed by
theories ofbehavior change, and investigators
have paid little attention to the psychological
factors that may interact with testing to affect
behavior. This atheoretical approach contrasts with other contemporary HIV prevention interventions,71 in which researchers typically examine the effects of an intervention
on theoretical determinants of risk behavior
(e.g., HIV-related skills, perceived social
norms, and intentions for behavior change).
Assessing the hypothesized determinants of
behavior can help to identify mechanisms
of change, is central to the iterative process
of theory-driven research, and can guide the
development and refinement of interventions.
For example, a theoretical firmework that
is often applied to the design and evaluation of
HIV risk reduction interventions is the Information-Motivation-Behavioral Skills model of
AIDS preventive behavior.72 According to this
model, the effects of HIV-related information
and risk reduction motivation on sexual
behavior are mediated by the use of specific
September 1999, Vol. 89, No. 9
HIV Counseling and Testing
TABLE 3-Associations between Continuous Study Characteristics and Sexual
Behavior Effect Sizes in 27 Studies of HIV Counseling and Testing
k
p3a
QEb
15
17
17
.86*
.04
.02
60.09
43.85
78.21
14
12
12
.09
.25*
-.14
54.86
30.82
72.68
16
17
17
-.14
-.04
.17
68.55
43.56
75.91
11
13
12
-.01
.05
-.22
28.03
36.71
58.05
16
17
17
-.21
-.01
.53*
66.68
43.94
56.11
Moderator and Study Outcome
Seroprevalence of participants
Unprotected sex
Condom use
No. of sexual partners
Age of participants
Unprotected sex
Condom use
No. of sexual partners
Sex of participants
Unprotected sex
Condom use
No. of sexual partners
Attrition rate
Unprotected sex
Condom use
No. of sexual partners
Length of follow-up
Unprotected sex
Condom use
No. of sexual partners
Note. k= number of effect sizes included in analysis; ,B = standardized regression weight;
QE= homogeneity statistic.
aAnalyses were controlled for HIV-serostatus group.
bAll significant at P<.01.
*P< .005.
behavioral skills, such as condom negotiation
with a sexual partner and the ability to apply a
condom correctly. Without such behavioral
skills, a well-informed and motivated individual may find it difficult to modify his or her
sexual risk behavior. Other theoretically relevant factors that may predict behavioral change
in HIV-CT are participants' estimation of their
odds of being infected with HIV73 and participants' appraisal of and method of coping with
the potential threat of learning that they are
HIV-seropositive.74 Assessing these constructs
before and after HLV-CT would permit stronger
inferences about the effects of the intervention
on these moderators; HIV-CT procedures
could then be modified to produce a greater
impact on behavior.
In this meta-analysis, volition for testing
and injection drug use treatment status were
the only moderators that could be construed
as proxies for psychological factors, but both
are sample characteristics that remained consistent throughout the course of the studies.
None of the moderating variables that could
be tested represented modifiable constructs,
such as information, motivation, or behavioral
skills. If we are to understand and enhance
HIV-CT's effectiveness in reducing risk
behavior, we must be guided by theories of
behavior change and we must measure key
constructs.
A second limitation of the HIV-CT literature involves the absence of details about
counseling. Although the CDC provides
September 1999, Vol. 89, No. 9
technical guidance for HIV test counseling,"
many counselors may disregard these guidelines,75 believing that risk reduction counseling is ineffective.76 If variations in counseling
technique are not documented, our ability to
evaluate the effects of HIV-CT is limited.
Failure to specifically defme the independent
variable threatens the validity of any study77
and in this case makes it difficult to determine
what components of HIV-CT are responsible
for behavior change. In the absence of details
about the counseling, what the current metaanalysis provides is an evaluation of the
effects on risk behavior of the experience of
counseling and testing. However, an important question remains unanswered: Do different amounts and qualities of pretest and
posttest counseling result in differences in
risk reduction? A study of a large randomized
controlled trial of HIV-CT among heterosexual HIV-negative participants in urban STD
clinics, published while this article was in
press, begins to answer this question. The
CDC's Project RESPECT found that, compared with standard HIV-CT procedures,
enhanced counseling consisting of either 2 or
4 interactive sessions resulted in increased
condom use and decreased STD infections.78
Conclusions
Five conclusions can be drawn from this
meta-analysis of the HIV-CT literature:
1. HIV-CT appears to provide an effective means of secondary prevention for HIVpositive individuals. HIV-positive individuals
who underwent HIV-CT increased their safersex behaviors and reduced their risk behaviors, thereby decreasing their likelihood of
infecting others or becoming reinfected with
HIV or other STDs. The significant variability in study outcomes suggests that there is
much more to learn about the conditions
under which HIV-CT is effective in reducing
risk behavior and sustaining risk behavior
change among HIV-positive participants.
2. HIV-CT, at least as it was implemented in the studies reviewed, does not
appear to be an effective intervention for the
primary prevention of HIV infection. HIVnegative individuals did not reduce their risk
behavior, relative to untested participants,
after HIV-CT. However, because inadequate
attention has been paid to the psychological
and social contexts of testing, the theoretical
grounding of counseling, and the type and
amount of counseling provided, a closer
examination of these factors may reveal that
HIV-CT is effective with HIV-negative individuals under some circumstances.
3. Theory-driven research is needed to
further explicate the determinants ofbehavior
change in HIV-CT Programmatic research is
needed to isolate the psychological deterninants of behavior change associated with
HIV-CT and to develop and evaluate theoryguided interventions. An appropriate conceptual framework for HIV-CT needs to take into
account the context of testing. For example,
HIV-CT may be obtained by couples at the
beginning of a monogamous sexual relationship. Such individuals would not be expected
to increase their condom use and may in fact
increase their frequency of unprotected intercourse. Studies that attempt to evaluate the
effectiveness of HIV-CT would benefit from
obtaining and reporting more specific information about participants' relationship status,
reasons for seeking testing, and testing history.
4. Research is needed to examine the
effectiveness of specific counseling approaches. Research should examine the
effects of theory-based counseling with different contents, modes of delivery, and levels
of intensity. For example, the amount of
counseling provided with standard HIV-CT
(i.e., 5 to 10 minutes of pretest counseling
and 10 to 30 minutes of posttest counseling)
may not be sufficient to increase motivation
for behavior change in most individuals. In
contrast to other HIV-related behavioral interventions, the amount of counseling typically
provided in HIV-CT is inadequate to foster a
reduction in risk behavior.71 Future research
might also address the role of counseling in
American Journal of Public Health
1403
Weinhardt et al.
the context of new home testing and rapid
testing technologies.7982
5. HIV-CTshould be viewed as one part
of an overall HIVprevention strategy that
also includes individual-, community-, and
policy-level interventions. Despite the widespread use of HIV-CT, it should not be
regarded as the sole strategy for HIV prevention. Rather, HIV-CT should be viewed as
one part of a comprehensive set of strategies,
drawing on programs that have been shown
to be effective for primary prevention.83
These strategies should target not only the
individual, as in interpersonal skills training
programs,84 but also communities85 and
social policies.86 It is only through integrated
efforts at these multiple levels that the HIV
epidemic will be addressed adequately. D
Contributors
L. S. Weinhardt and M. P. Carey conceptualized the
study and developed the initial proposal for the project. L. S. Weinhardt completed the literature search,
developed the coding protocol, and assembled the
research materials for coding. L. S. Weinhardt and
N. L. Bickham coded study characteristics. L. S.
Weinhardt and B. T. Johnson calculated the effect
sizes and conducted the analyses. All authors interpreted the results. L. S. Weinhardt and M. P Carey
prepared the initial draft of the manuscript. All
authors revised the initial draft and approved the
final version of the paper.
Acknowledgments
This study was supported by grants from the National
Institute of Mental Health (K2 1 -MH0 110, K2 1MH01377, and F31-MH11125).
References
1. Centers for Disease Control and Prevention.
HI VAIDS Surveillance Report. 1998; 10(1).
2. Rosenberg PS. Scope of the AIDS epidemic in
the United States. Science. 1995;270:1372-1375.
3. DeCock KM, Barrere B, Diaby L. AIDS: the
leading cause of adult death in the West African
city of Abidjan, Ivory Coast. Science. 1990;
249:793-796.
4. Mulder DW, Nunn AJ, Kamali A, Nakiyingi J,
Wagner HU, Kengeya-Kayondo JF. Two-year
HIV- 1 associated mortality in a Ugandan rural
population. Lancet. 1994;343:1021-1023.
5. Bartlett JG. Protease inhibitors for HIV infection. Ann Intern Med. 1996;124:1086-1088.
6. Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on
treatment of HIV-infected tuberculosis patients
with rifampin. MMWR Morb Mortal Wkly Rep.
1996;45:921-925.
7. Holmberg SD, Curran JW. The epidemiology of
HIV infection in industrialized countries. In:
Holmes KK, Mardh PA, Sparling PF, et al., eds.
Sexually Transmitted Diseases. 2nd ed. New
York, NY: McGraw-Hill; 1990:343-353.
8. Mann J, Tarantola D.AIDS in the World II: Global
Dimensions, Social Roots, and Responses. New
York, NY: Oxford University Press; 1996.
1404 American Journal of Public Health
9. Campbell CH Jr, Marum ME, Alwano-Edyegu
M, Dillon BA, Moore M, Gumisiriza E. The
role of HIV counseling and testing in the developing world. AIDS Educ Prev. 1997;9(Suppl B):
92-104.
10. Centers for Disease Control and Prevention.
Technical guidance on HIV counseling. MMWR
Morb Mortal Wkly Rep. 1993;42(RR-2):11-16.
11. Anderson JE. CDC data systems collecting
behavioral data on HIV counseling and testing.
Public Health Rep. 1996;1 1: 129-132.
12. Shoenborn CA, Marsh SL, Hardy AM. AIDS
Knowledge and Attitudes for 1992: Data
From the National Health Interview Survey.
Hyattsville, Md: National Center for Health
Statistics; 1994.
13. HIV Counseling and Testing in Publicly Funded
Sites: 1993-1994 Summary Report. Atlanta,
Ga: Centers for Disease Control and Prevention; 1996.
14. Weber JT, Frey RL Jr, Horsley R, Gwinn ML.
Publicly funded HIV counseling and testing in
the United States, 1992-1995. AIDS Educ Prev.
1997;9(Suppl B):79-91.
15. Holtgrave DR, Valdiserri RO, Gerber R, Hinman AR. Human immunodeficiency virus
counseling, testing, referral, and partner notification services: a cost-benefit analysis. Arch
Intern Med. 1993;153:1225-1230.
16. Doll LS, Kennedy MB. HIV counseling and
testing: what is it and how well does it work?
In: Schochetman G, George JR, eds. AIDS Testing: A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues.
2nd ed. New York, NY: Springer-Verlag; 1994:
302-319.
17. Cates W Jr, Handsfield HH. HIV counseling
and testing: does it work? Am J Public Health.
1988;78: 1533-1534.
18. Coates TJ, Stall RD, Kegeles SM, Lo B, Morin
SF, McKusick L. AIDS antibody testing: will it
stop the AIDS epidemic? will it help people
infected with HIV? Am Psychol. 1988;43:
859-864.
19. Higgins DL, Galavotti C, O'Reilly KR, et al.
Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA.
1991;266:2419-2429.
20. Rugg DL, MacGowan RJ, Stark KA, Swanson
NM. Evaluating the CDC program for HIV
counseling and testing. Public Health Rep.
1991;106:708-713.
21. Phillips KA, Coates TJ. HIV counseling and
testing: research and policy issues. AIDS Care.
1995;7:115-124.
22. Wolitski RJ, MacGowan RJ, Higgins DL, Jorgensen CM. The effects of HIV counseling and
testing on risk-related practices and help-seeking behavior. AIDS Educ Prev. 1997;9(Suppl B):
52-67.
23. Hunt M. How Science Takes Stock: The Story of
Meta-Analysis. New York, NY: Russell Sage;
1997.
24. Rosenthal R. Meta-Analytic Procedures for
Social Research. Newbury Park, Calif: Sage
Publishing; 1991.
25. Col6n HM, Robles RR, Marrero CA, Reyes JC,
Sahai H. Behavioral effects of receiving HIV
test results among injecting drug users in
Puerto Rico. AIDS. 1996;10:1163- 1168.
26. Magura 5, Siddiqi Q, Shapiro J, et al. Outcomes
of an AIDS prevention program for methadone
patients. Int JAddict. 1991 ;26:629-655.
27. Adib SM, Joseph JG, Ostrow DG, Tal M,
Schwartz SA. Relapse in sexual behavior
among homosexual men: a 2-year follow-up
from the Chicago MACS/CCS. AIDS. 199 1;5:
757-760.
28. van Griensven GJ, de Vroome EM, Tielman
RA, et al. Impact of HIV antibody testing on
changes in sexual behavior among homosexual
men in the Netherlands. Am J Public Health.
1988;78:1575-1577.
29. Kuiken CL, van Griensven GJ, de Vroome EM,
Coutinho RA. Risk factors and changes in sexual behavior in male homosexuals who seroconverted for human immunodeficiency virus antibodies. Am J Epidemiol. 1990; 132:523-530.
30. McCusker J, Stoddard AM, Mayer KH, Zapka
J, Morrison C, Saltzman SP. Effects of HIV
antibody test knowledge on subsequent sexual
behaviors in a cohort of homosexually active
men [published correction appears in Am J
Public Health. 1988;78:1530]. Am J Public
Health. 1988;78:462-467.
31. McKusick L, Coates TJ, Morin SF, Pollack L,
Hoff C. Longitudinal predictors of reductions in
unprotected anal intercourse among gay men in
San Francisco: the AIDS Behavioral Research
Project. Am JPublic Health. 1990;80:978-983.
32. Morrill AC, Ickovics JR, Golubchikov VV,
Beren SE, Rodin J. Safer sex: social and psychological predictors of behavioral maintenance and change among heterosexual women.
J Consult Clin Psychol. 1996;64:819-828.
33. Cohen J. Coefficient of agreement for nominal
scales. Educ Psychol Meas. 1960;20:37-46.
34. Johnson BT DSTAT 1.10: Software for the MetaAnalytic Review ofResearch Literatures: Upgrade
Documentation. Hillsdale, NJ: Lawrence Erlbaum; 1993.
35. Cohen J. Statistical Power Analysis for the
Behavioral Sciences. 2nd ed. New York, NY:
Academic Press; 1977.
36. Hedges LV. Distribution theory for Glass's
estimator of effect size and related estimators.
JEduc Stat. 1981;6:107-128.
37. Johnson BT, Eagly AH. Quantitative synthesis
of social psychological research. In: Reis HT,
Judd CM, eds. Handbook of Research Methods
in Social Psychology. London, England: Cambridge University Press. In press.
38. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press;
1980.
39. Hedges LV, Olkin I. Statistical Methods for
Meta-Analysis. Orlando, Fla: Academic Press;
1985.
40. Orwin RG. A fail-safe N for effect size in metaanalysis. JEduc Stat. 1983;8:157-159.
41. Allen S, Serufilira A, Bogaerts J, et al. Confidential HIV testing and condom promotion in
Africa: impact on HIV and gonorrhea rates.
JAMA. 1992;268:3338-3343.
42. Allen S, Tice J, Van de Perre P, et al. Effect of
serotesting with counselling on condom use and
seroconversion among HIV discordant couples
in Africa. BMJ 1992;304:1605-1609.
43. Calsyn DA, Saxon AJ, Freeman G Jr, Whittaker
S. Ineffectiveness of AIDS education and HIV
antibody testing in reducing high-risk behaviors
among injection drug users. Am JPublic
Health. 1992;82;573-575.
44. Casadonte PP, DesJarlais DC, Friedman SR,
Rotrosen JP. Psychological and behavioral
impact among intravenous drug users of learning HIV test results. Int JAddict. 1990;25:
409-426.
September 1999, Vol. 89, No. 9
HIV Counseling and Testing
45. Cleary PD, Van Devanter N, Rogers TF, et al.
Behavior changes after notification of HIV infection. Am J Public Health. 1991;81:1586-1590.
46. Coates TJ, Morin SF, McCusick L. Behavioral
consequences of AIDS antibody testing among
gay men. JAMA. 1987;258:1889.
47. Doll L, O'Malley PM, Pershing AL, Darrow
WW, Hessol NA, Lifson AR. High-risk sexual
behavior and knowledge of HIV antibody status
in the San Francisco city clinic cohort. Health
Psychol. 1990;9:253-265.
48. Fox R, Odaka NJ, Brookmeyer R, Polk BF.
Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS.
1987; 1:241-246.
49. van Griensven GJ, de Vroome EM, Tielman
RA, et al. Effect of human immunodeficiency
virus (HIV) antibody knowledge on high-risk
sexual behavior with steady and nonsteady sexual partners among homosexual men. Am JEpidemiol. 1989;129:596-603.
50. Huggins J, Elman N, Baker C, Forrester RG,
Lyter D. Affective and behavioral responses of
gay and bisexual men to HIV antibody testing.
Soc Work. 1991;36:61-66.
51. Ickovics JR, Morrill AC, Beren SE, Walsh U,
Rodin J. Limited effects of HIV counseling and
testing for women. JAMA. 1994;272:443-448.
52. Jackson DJ, Rakwar JP, Richardson BA, et al.
Decreased incidence of sexually transmitted
diseases among trucking company workers in
Kenya: results of a behavioural risk-reduction
programme. AIDS. 1997; 11:903-909.
53. Kamenga M, Ryder RW, Jingu M, et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149
married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in
Zaire. AIDS. 1991;5:61-67.
54. Landis SE, Earp JL, Koch GG. Impact of HIV
testing and counseling on subsequent sexual
behavior. AIDS Educ Prev. 1992;4:61-70.
55. Magura S, Shapiro JL, Grossman JI, et al.
Reactions of methadone patients to HIV antibody testing. Adv Alcohol Subst Abuse. 1990;
8:97-111.
56. McCusker J, Willis G, McDonald M, Serett SM,
Lewis BF, Sullivan JL. Community-wide HIV
counseling and testing in central Massachusetts:
who is retested and does their behavior change?
J Community Health. 1996;21:11-23.
57. Muller 0, Barugahare L, Schwartlander B, et al.
HIV prevalence, attitudes and behavior in clients
of a confidential HIV testing and counselling
centre in Uganda. AIDS. 1992;6:869-874.
58. Nicolosi A, Molinari S, Musicco M, Saracco A,
Ziliani N, Lazzarin A. Positive modification of
injecting behavior among intravenous heroin
September 1999, Vol. 89, No. 9
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
users from Milan and Northern Italy 1987-1989.
BrJAddict. 1991;86:91-102.
Ostrow DG, Joseph JG, Kessler R, et al. Disclosure of HIV antibody status: behavioral and
mental health correlates. AIDS Educ Prev.
1989;1:1-1 1.
Otten MW, Zaidi AA, Wroten JE, Witte JJ,
Peterman TA. Changes in sexually transmitted
disease rates after HIV testing and posttest
counseling, Miami, 1988 to 1989. Am JPublic
Health. 1993;83:529-533.
Padian NS, O'Brien TR, Chang Y, Glass S,
Francis DP. Prevention of heterosexual transmission of human immunodeficiency virus
through couple counseling. JAcquir Immune
Defic Syndr. 1993;6:1043-1048.
Pickering H, Quigley M, Pepin J, Todd J,
Wilkins A. The effects of post-test counseling
on condom use among prostitutes in The Gambia. AIDS. 1993;7:271-273.
Schechter MT, Craib KJP, Willoughby B, et al.
Patterns of sexual behavior and condom use in a
cohort of homosexual men. Am JPublic Health.
1988;78:1535-1538.
Wenger NS, Greenberg JM, Hilborne LH, Jusseling F, Mangotich M, Shapiro M. Effect of
HIV antibody testing and AIDS education on
communication about HIV risk and sexual
behavior: A randomized, controlled trial in college students. Ann Intern Med. 1992; 117:
905-911.
Wenger NS, Linn LS, Epstein M, Shapiro MF.
Reduction of high-risk sexual behavior among
heterosexuals undergoing HIV antibody testing: a randomized clinical trial. Am J Public
Health. 1991;81:1580-1585.
Wilson TE, Jaccard J, Levinson RA, Minkoff H,
Endias R. Testing for HIV and other sexually
transmitted diseases: implications for risk
behavior in women. Health Psychol. 1996; 15:
252-260.
Zapka JG, Stoddard A, Zorn M, McCusker J,
Mayer KH. HIV antibody test result knowledge, risk perceptions and behavior among
homosexually active men. Patient Educ Couns.
1991;18:9-17.
Raudenbush SW Random effects models. In:
Cooper H, Hedges LV, eds. The Handbook of
Research Synthesis. New York, NY: Russell
Sage; 1994:301-321.
St. Lawrence JS, Hood HV, Brasfield T, Kelly
JA. Differences in gay men's AIDS risk knowledge and behavior patterns in high and low
AIDS prevalence cities. Public Health Rep.
1989;104:391-395.
70. Lupton D, McCarthy S, Chapman S. Doing the
right thing: symbolic meanings and experiences
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
of having an HIV antibody test. Soc Sci Med.
1995;41:173-180.
Kalichman SC, Carey MP, Johnson BT. Prevention of sexually transmitted HIV infection: a
meta-analytic review of the behavioral outcome
literature. Ann Behav Med. 1996; 18:6-15.
Fisher JD, Fisher WA. Changing AIDS risk
behavior. Psychol Bull. 1992;1 11:455-474.
Kahneman D, Tversky A. On the psychology of
prediction. Psychol Rev. 1973;80:237-251.
Lazarus RS, Folkman S. Stress, Appraisal, and
Coping. New York, NY: Springer; 1984.
Beardsell S, Coyle A. A review of research on
the nature and quality of HIV testing services: a
proposal for process-based studies. Soc Sci
Med. 1996;42:733-743.
Beardsell S. Should wider HIV testing be
encouraged on the grounds of HIV prevention?
AIDS Care. 1994;6:5-19.
Cook TD, Campbell DT. Quasi-Experimentation: Design and Analysis Issues for Field Settings. Boston, Mass: Houghton Mifflin; 1979.
Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk reduction counseling to prevent
human immunodeficiency virus and sexually
transmitted diseases: a randomized controlled
trial. JAMA. 1998;280:1161-1167.
Branson BM. Home sample collection tests for
HIV infection. JAMA. 1998;280: 1699-1701.
Gallo D, George JR, Fitchen JH, Goldstein AS,
Hindahl MS. Evaluation of a system using oral
mucosal transudate for HIV-1 antibody screening
and confirmatory testing. JAMA. 1997;277:
254-258.
Kassler WJ. Advances in HIV testing technology and their potential impact on prevention.
AIDS Educ Prev. 1997;9(Suppl B):27-40.
Mashu A, Mbizvo MT, Makura E, et al. Evaluation of rapid on-site clinic HIV test, combined
with counselling. AIDS. 1997;1 1:932-933.
Interventions to prevent HIV risk behaviors.
NIH consensus statement. 1997; 15(2): 1-41.
Available at: http://odp.od.nih.gov/consensus/
cons/104/104_intro.htm. Accessed May 1999.
Carey MP, Maisto SA, Kalichman SC, Forsyth
AD, Wright EM, Johnson BT. Enhancing motivation to reduce the risk of HIV infection for
economically disadvantaged urban women.
J Consult Clin Psychol. 1997;65:531-541.
Kelly JA, St. Lawrence JS, Stevenson LY, et al.
Community AIDS/HIV risk reduction: the
results of endorsements by popular people in
three cities. Am JPublic Health. 1992;82:
1483-1489.
Watters JK, Estilo MJ, Clark GL, Lovrick J.
Syringe and needle exchange as HIV/AIDS
prevention for injection drug users. JAMA.
1994;217:115-120.
American Journal of Public Health 1405